Two studies suggest that an experimental peptide vaccine and a peptide therapeutic used either together or individually with a low-dose of a standard chemotherapy drug, might offer more effective cancer therapy than current standard single-drug treatments. The studies, done in breast-cancer models, show that the peptide combinations dramatically delay tumor onset and progression by both inhibiting tumor growth and blocking the formation of new tumor blood vessels.